glp-1 stock market Eli Lilly has consolidated its dominance of the US over Novo Nordisk, with total prescriptions increasing 41% year-over-year. #beststocks #stocks #stockmarket #trading #investment #thesmartinvestortool GLP-1 Receptor Agonist Market Growth

Dat geldt alleen als de behandeling voldoende resultaat geeft en er geen ernstige bijwerkingen zijn

GLP-1 drugs act much more slowly, with the goal of a more permanent result

Patients were on standard of care therapy

But markets dont run on peak efficacy alone

IGF-1 has a U-shaped relationship with health

Microdosing GLP-1s generally refers to taking less than the typical doses, perhaps to save money or reduce side effects, though Hims bills it as a treatment for general metabolic health. The microdose treatment will cost the same as the rest of its compounded GLP-1s, currently $1,200 for a six-month plan paid up front